Sign inJoin waitlistJoin the waitlist

JH

Jing-Zhou Hou

Physician · Upmc

Credentials: · · · ·

History

Upmc
Present

Hematology
1989–1990
Internal Medicine
1986–1989
Doctor of Medicine
1982–1986

Research

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Blood · 2020 · 646 citations
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
Journal of Clinical Oncology · 2019 · 557 citations
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Blood · 2008 · 333 citations

AR
Anastasios Raptis
24 papers
MB
Michael Boyiadzis
24 papers
MA
Mounzer Agha
24 papers
Annie Im
20 papers
KD
Kathleen Dorritie
18 papers
RF
Rafic Farah
17 papers
Robert Redner
17 papers
Alison Sehgal
16 papers
SL
Seah Lim
9 papers
Konstantinos Lontos
8 papers · 2 as a fellow
Stanley Marks
7 papers
JR
James Rossetti
6 papers

Clinical trials

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2026–2030
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2027